Arch Neurol Chicago
-
Arch Neurol Chicago · Apr 2003
Multicenter StudyVaccinations and risk of central nervous system demyelinating diseases in adults.
Several case reports of the onset or exacerbation of multiple sclerosis or other demyelinating conditions shortly after vaccination have suggested that vaccines may increase the risk of demyelinating diseases. ⋯ Vaccination against hepatitis B, influenza, tetanus, measles, or rubella is not associated with an increased risk of multiple sclerosis or optic neuritis.
-
Arch Neurol Chicago · Apr 2003
Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma.
Long-term neurotoxicity is a frequent complication of combined radiotherapy and chemotherapy in patients with primary central nervous system lymphoma. Treatment protocols without radiotherapy have been implemented to avoid this; however, little detailed neuropsychologic and neuroradiologic data exist to assess the frequency of long-term treatment sequelae in this patient group. ⋯ We conclude that chemotherapy alone is associated with a low risk of long-term neurotoxicity in primary central nervous system lymphoma. Methotrexate-induced white matter lesions detectable on magnetic resonance imaging are not inevitably associated with significant cognitive decline.
-
Arch Neurol Chicago · Oct 2002
Randomized Controlled Trial Multicenter Study Clinical TrialEffects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.
Parkinson disease (PD) is a degenerative neurological disorder for which no treatment has been shown to slow the progression. ⋯ Coenzyme Q10 was safe and well tolerated at dosages of up to 1200 mg/d. Less disability developed in subjects assigned to coenzyme Q10 than in those assigned to placebo, and the benefit was greatest in subjects receiving the highest dosage. Coenzyme Q10 appears to slow the progressive deterioration of function in PD, but these results need to be confirmed in a larger study.
-
Arch Neurol Chicago · Jul 2002
Meta AnalysisThe role of hypothermia in the management of severe brain injury: a meta-analysis.
Hypothermia is utilized in the management of severe traumatic brain injury despite the lack of unequivocal evidence supporting its use. Because of its widespread use, the effects of hypothermia are a concern. ⋯ This meta-analysis of randomized controlled trials suggests that hypothermia is not beneficial in the management of severe head injury. However, because hypothermia continues to be used to treat these injuries, additional studies are justified and urgently needed.